Illuminate Child and Adolescent Bipolar 1 Depression Study

Heads Up, We're Moving!

  • Posted on: 22 November 2016
  • By: IFBM

The Institute for Behavioral Medicine is moving 5 minutes down South Cobb Drive to our recently acquired building! Please bear with us during our transition and contact us ahead of time to confirm the address of your appointment. We are still seeing most patients at 4015 S Cobb Dr through this transition. 

Our new address is:

696 Concord Rd SE
Smyrna, GA 30082

We're right across the street from Varners Restaurant by the Kroger shopping center at the corner of S Cobb Dr and Concord Rd SE. The building currently has a HOPCO Marketing sign in front. We're renovating the front so in the short term we encourage you to use the side door for easy access should you be scheduled there. These are exciting times, Happy Holidays!



Welcome to the Institute for Behavioral Medicine. Since 2004, our center has been a facilitator of comprehensive mental health care to families in the metro Atlanta region, serving Child, Adolescent and Adult clients. IFBM Outpatient Clinical Care begins with psychiatric evaluation necessary to identify mood and behavioral health disorders. Options for conservative medications management are discussed with clients and caregivers when appropriate and consistent with excellent standard of care. Referrals to psychologists, therapists, research participation, inpatient care, and cutting edge treatment options facilitate the building of a full treatment team for those individuals who would benefit from comprehensive mental health care. New patients should  contact IFBM Clinical.

IFBM Research is proud to be an active research site for major pharmaceutical companies. Ashraf Attalla, M.D. is our Director of Clinical Research. Clinical research is necessary to the process of obtaining FDA approval for medications used in treating a variety of mental health disorders. Our site is dedicated to important clinical research studies needed to determine the effectiveness and safety of new medications as well as new uses of approved medications. 

Our physicians are enrolling adolescents who have symptoms and meet criteria for indications such as ADHD, Autism, Bipolar Disorder, Major Depressive Disorder, Schizophrenia, and Fibromyalgia. Participation includes a focused evaluation and medical safety exam at no cost to the participant. Eligible participants accepted into trial participation receive study medications at no cost, and may be eligible for travel reimbursements.  

Current Clinical Trials Flyer

If you are interested in voluntary clinical trial participation, contact IFBM Research to schedule your complimentary phone interview or office meet-and-greet session.